Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

This study has been completed.
Agenzia Italiana del Farmaco
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research Identifier:
First received: June 29, 2007
Last updated: May 31, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):